Shopping Cart
- Remove All
Your shopping cart is currently empty
RET-IN-23 is an orally available and highly potent RET inhibitor with significant antitumor activity for the study of non-small cell lung cancer.

| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 1 mg | $293 | In Stock | |
| 5 mg | $722 | In Stock | |
| 10 mg | $987 | In Stock | |
| 25 mg | $1,520 | In Stock |
| Description | RET-IN-23 is an orally available and highly potent RET inhibitor with significant antitumor activity for the study of non-small cell lung cancer. |
| Targets&IC50 | RET (M918T):1.47 nM, RET (V804M):1.03 nM, RET (CCDC6):2.50 nM, RET (V804L):6.54 nM, RET (WT):1.32 nM |
| In vitro | RET-IN-23 is a potent and orally active RET inhibitor with IC50 of 1.32, 2.50, 6.54, 1.03, and 1.47 nM for RET-WT, RET-CCDC6, RET-V804L, RET-V804M, and RET-M918T, respectively. [1] |
| In vivo | RET-IN-23 exhibited significant antitumor activity in mice after oral administration at a dose of 5 mg/kg. [1] |
| Molecular Weight | 537.59 |
| Formula | C28H28FN11 |
| Cas No. | 2479961-46-9 |
| Smiles | FC=1C=NN(C1)C2=NC=C(C=C2)CN3C4CN(C5=NC=C(C=C5)C6=NC(=CC(=N6)C)NC7=NNC(=C7)C)CC3C4 |
| Storage | store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.